US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
BioPharma Credit PLC (PK) (BOPCF) 銘柄情報

BioPharma Credit PLC (PK) (BOPCF)

0.98

0.00

(0.00%)

終了 6月20日 5:00AM

BioPharma Credit PLC (PK) (BOPCF) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.98

( - )

買値

0.585

売値

1.38

出来高

-

0.00 日の範囲 0.00

0.8364 52 週間の範囲 1.02

時価総額

前日終値

0.98

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

US$ 1,463,280

発行済株式数

1,129,227,778

配当利回り

0.07 (10.70%)

PER

8.28

1 株当たり利益 (EPS)

0.11

歳入

157.75M

純利益

129.89M

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingd... BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom. 詳細を表示

セクター

Finance

業界

Asset Management Services

ウェブサイト

www.bpcruk.com

本社

London, United Kingdom

設立

2026

BioPharma Credit PLC (PK) is listed in the Finance sector of the その他OTC with ticker BOPCF. The last closing price for BioPharma Credit (PK) was US$0.98. Over the last year, BioPharma Credit (PK) shares have traded in a share price range of US$ 0.8364 to US$ 1.02.

BioPharma Credit (PK) currently has 1,129,227,778 shares in issue. The market capitalisation of BioPharma Credit (PK) is US$1.11 billion. BioPharma Credit (PK) has a price to earnings ratio (PE ratio) of 8.28.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.98	0.98	0.98	1000	0.98	CS
4	0.02	2.08333333333	0.96	0.98	0.90752	798000	0.90770375	CS
12	-0.02	-2	1	1.02	0.8794	569202	0.93437643	CS
26	0.1297	15.2534399624	0.8503	1.02	0.8503	387730	0.9331492	CS
52	0.07	7.69230769231	0.91	1.02	0.8364	399867	0.9202316	CS
156	-0.27	-21.6	1.25	1.25	0.54044	290439	0.9107926	CS
260	0.04	4.25531914894	0.94	1.25	0.54044	232829	0.91925099	CS

BOPCF - Frequently Asked Questions (FAQ)

What is the current BioPharma Credit PLC (PK) share price?

The current share price of BioPharma Credit PLC (PK) is US$ 0.98

How many BioPharma Credit PLC (PK) shares are in issue?

BioPharma Credit PLC (PK) has 1,129,227,778 shares in issue

What is the market cap of BioPharma Credit PLC (PK)?

The market capitalisation of BioPharma Credit PLC (PK) is USD 1.11B

What is the 1 year trading range for BioPharma Credit PLC (PK) share price?

BioPharma Credit PLC (PK) has traded in the range of US$ 0.8364 to US$ 1.02 during the past year

What is the PE ratio of BioPharma Credit PLC (PK)?

The price to earnings ratio of BioPharma Credit PLC (PK) is 8.28

What is the cash to sales ratio of BioPharma Credit PLC (PK)?

The cash to sales ratio of BioPharma Credit PLC (PK) is 6.73

What is the registered address of BioPharma Credit PLC (PK)?

The registered address for BioPharma Credit PLC (PK) is 51 Lime Street, London, Greater London, EC3M 7DQ

What is the BioPharma Credit PLC (PK) website address?

The website address for BioPharma Credit PLC (PK) is www.bpcruk.com

Which industry sector does BioPharma Credit PLC (PK) operate in?

BioPharma Credit PLC (PK) operates in the Asset Management Services sector

Investor082

Investor082 6分前

Gary, you have been saying that since 5 or more years. Your forecast was $23+ back in 2022. You missed by 10X or more there. You have consistently missed the mark by more than 10X every year. But this year we are looking forward to a record breaking 100X miss. Way to go! ;)

You are an

Investor082

Investor082 13分前

SpaceX may never come back to day 0 IPO listing price, but the bigger story undoubtedly will be Anthropic. It will become one of the biggest companies in the world in just a few years. You can count on their management to deliver excellent ROI, and no due diligence or daily message board monitoring

Cflores32097

Cflores32097 21分前

Whatever you do anyone seeing this, do not put your money into this… it’s a shell full of fake news articles fake merge deals buy some guy named Frank Pinizzotto in the Philippines this is his source of income they are a bunch of grifter who dish out stock to their friends wait for it to clear put o

INV4

Quantum sensors could spot hidden damage in the thousands of US bridges rated ‘structurally deficient’

June 19 , 2026

By Alex Krasnok, Assistant Professor of Electrical & Computer Engineering, Florida International University

https://www.chron.com/news/a

RDY2ROCK

RDY2ROCK 43分前

🚀🚀🤑🤑 $TXTM 🤑🤑🚀🚀

I’ve been invested in TXTM since RSAMMDA LLC acquired TXTM JUN 2022 and one of the reasons they acquired TXTM was for their Extraction Technology to go along with their Kettle system! And now they have int

thistraderknowsall

thistraderknowsall 1時間前

$BTC.X Nice rebound!!! Now taking sister BICO Crypto surges to $23 great AI developments! like RAVE did in April.. #1 next runner-up! Congrats! BICO $23

thistraderknowsall

thistraderknowsall 1時間前

$BTC.X Nice rebound!!! Now taking sister BICO Crypto surges to $23 great AI developments! like RAVE did in April.. #1 next runner-up! Congrats! BICO $23

FanOfspringsteen

FanOfspringsteen 2時間前

Yes. We cannot force a company to sign a licensing agreement (for future usage) but we can, on the other hand, make it pay dearly for the past infraction so that it is more inclined to sign an agreement.

Mr.anderson1

Mr.anderson1 3時間前

I hope they read this.

dinogreeves

dinogreeves 3時間前

Beautiful set up.

dinogreeves

dinogreeves 3時間前

Looking real good for next week. Something brewing for big run into to next year for sure.

leavetheguntakethecannolis

leavetheguntakethecannolis 3時間前

Looking silly? More like sounding desperate.

barnstormer

barnstormer 3時間前

Gary, I missed the 4 for 1 split for NVDA but did purchase subsequent at 56. Stock ran up to 1,000 and split 10 for 1, now is at 210. By my rough calculations, that's a total return 22 bagger. If only NWBO could manage a fraction of that. The NVDA problem is taxes will be a problem when I do decide

Teddytropics

Teddytropics 3時間前

Greedy, greedy Lo_2Hi..

Chomping up the cheapies..

Chomp, chomp, chomp..

😇😇😇

Chomp some more..

Yum, yum..

Missing 2016 financials...

Chomp, chomp, chomp..

CryptoRain

CryptoRain 3時間前

Nope..not a pump… and a few folks are going to look mighty silly

adagium

adagium 4時間前

Datacom Optical Component Revenue
$19B in 2025 => $7.7 Billion in 1Q26

Datacom Optical Component Revenue Doubles to $7.7 Billion in 1Q26
June 18, 2026
https://cignal.ai/2026/06/datacom-optical-component-revenue-doubles-to-7-7-billion-in-1q26/

Vendo

knrorrel

knrorrel 4時間前

By the way, if you drop another hint, you could also say which stock it is.

Nemesis18

Nemesis18 4時間前

Gary, at best you're a fantasist, at worst you're delusional.
Your investment is, all but GONE.

nowwhat2

nowwhat2 4時間前

https://investorshub.advfn.com/uimage/uploads/2026/6/18/iigwfeth_june_18_9y_tv_ANGEL_DESTINY_TRUST.jpg

Right ON The (10 year) Line
https://investorshub.advfn.com/uimage/uploads/2026/6/18/opedreth_june_18_10_11am_1666_ON_TL_snip.jpg

Yesterday ;

naveedkhan

naveedkhan 4時間前

Hopefull investor likely stressed so will surely go to spa for quick R&T from ur sister. She as fuggely as u so only cost equivalent of five FNMA shares.

BioPharma Credit (PK)

RBC Target 2026 Canadian...

CocaCola European Partners

1.75% 18jan2028

Exchange Traded Fund Jpm...

Bmo Low Volatility Us Eq...

Citigroup Global Markets...

Ci Global Reit Class Ser...

Chorus Ii Moderate Low V...

BetaShares Capital

Bmo Dividend Fund Series...

Ai Robotics & Technology...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。